US Biologic
US Biologic is a Memphis-based company dedicated to disease prevention through innovative oral vaccines and therapeutics. Their mission is to reduce disease globally by developing safe, effective, and cost-efficient vaccines and therapeutics for humans, animals, and wildlife, aiming to prevent pandemics and control zoonotic diseases at their source.
Industries
Nr. of Employees
small (1-50)
US Biologic
Memphis, Tennessee, United States, North America
Patents
Composition and method of an orally administered antimicrobial peptide vectored in a bacterial expression vehicle
US-11814628-B2
View Details
Composition and method of an orally administered antimicrobial peptide vectored in a bacterial expression vehicle
US-11814628-B2
View DetailsProducts
Wildlife-targeted vaccine delivery system (vaccine-coated bait/pellets)
Integrated control approach combining rodent/tick control methods with vaccine-coated bait/pellets designed to immunize reservoir hosts and reduce pathogen transmission.
Chewable oral influenza vaccine candidate
Preclinical chewable/edible oral vaccine candidate for influenza designed for room-temperature stability and needle-free administration.
Oral alternative therapeutic for poultry (coccidiosis)
Oral therapeutic formulation developed as an alternative to antibiotics for control of poultry coccidiosis.
Borrelia Burgdorferi Bacterin vaccine
A novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, spray-coated onto pellets consumed by white-footed mice.
Chewable Flu Vaccine
A chewable flu vaccine developed by US Biologic in partnership with BARDA, designed to increase vaccine equity, avoid needles, and reduce pandemics. It is thermostable, can be stored at room temperature, and shipped more easily than traditional flu vaccines.
OrisBio Oral-Delivery Vaccine Platform
A vaccine delivery platform designed for oral administration across different animal species, targeting the digestive tract for effective vaccine placement.
Wildlife-targeted vaccine delivery system (vaccine-coated bait/pellets)
Integrated control approach combining rodent/tick control methods with vaccine-coated bait/pellets designed to immunize reservoir hosts and reduce pathogen transmission.
Chewable oral influenza vaccine candidate
Preclinical chewable/edible oral vaccine candidate for influenza designed for room-temperature stability and needle-free administration.
Oral alternative therapeutic for poultry (coccidiosis)
Oral therapeutic formulation developed as an alternative to antibiotics for control of poultry coccidiosis.
Borrelia Burgdorferi Bacterin vaccine
A novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, spray-coated onto pellets consumed by white-footed mice.
Chewable Flu Vaccine
A chewable flu vaccine developed by US Biologic in partnership with BARDA, designed to increase vaccine equity, avoid needles, and reduce pandemics. It is thermostable, can be stored at room temperature, and shipped more easily than traditional flu vaccines.
OrisBio Oral-Delivery Vaccine Platform
A vaccine delivery platform designed for oral administration across different animal species, targeting the digestive tract for effective vaccine placement.
Services
Collaborative R&D of orally delivered vaccines and therapeutics for human and animal pathogens, including formulation, preclinical evaluation, and antigen integration.
Design, deployment, and evaluation of field studies to measure effectiveness of oral vaccine delivery mechanisms and integrated control strategies in target environments.
Management and execution of collaborative programs with federal agencies and academic partners for funded development and deployment projects.
Use of zoonotic surveillance data and predictive analytics to prioritize targets and guide oral vaccine design for pandemic prevention.
Collaborative R&D of orally delivered vaccines and therapeutics for human and animal pathogens, including formulation, preclinical evaluation, and antigen integration.
Design, deployment, and evaluation of field studies to measure effectiveness of oral vaccine delivery mechanisms and integrated control strategies in target environments.
Management and execution of collaborative programs with federal agencies and academic partners for funded development and deployment projects.
Use of zoonotic surveillance data and predictive analytics to prioritize targets and guide oral vaccine design for pandemic prevention.
Expertise Areas
- Oral vaccine development
- Zoonotic disease prevention
- Wildlife-targeted vaccine delivery
- Veterinary vaccine and therapeutic development
Key Technologies
- Oral vaccine delivery platforms
- Thermostable vaccine formulations
- Edible/chewable vaccine formulations
- Bait and pellet coating delivery systems
News & Updates
US Biologic announced the issuance of a U.S. patent for its composition and methods to reduce zoonotic infectious diseases, extending its platform for oral-delivery vaccines.
US Biologic announced the issuance of a U.S. patent for its composition and methods to reduce zoonotic infectious diseases, extending its platform for oral-delivery vaccines.